2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
28
Prostatic Neoplasms
16
Carcinoma, Non-Small-Cell Lung
10
Sarcoma
9
Lung Neoplasms
6
Uterine Cervical Neoplasms
5
Endometrial Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Pancreatic Neoplasms
3
Neoplasms
3
Liposarcoma, Myxoid
3
Head and Neck Neoplasms
3
Glioblastoma
3
Carcinoma, Intraductal, Noninfiltrating
3
Breast Carcinoma In Situ
3
Urogenital Neoplasms
2
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma, Synovial
2
Radiation Injuries
2
Neurofibrosarcoma
2
Neoplasm Metastasis
2
Melanoma
2
Lymphatic Metastasis
2
Liposarcoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Fibrosarcoma
2
Cholangiocarcinoma
2
Interventions
Indocyanine Green
7
Lymph Node Excision
6
Surgical Procedures, Operative
5
Radiotherapy, Intensity-Modulated
4
Radiotherapy
4
Radiosurgery
4
Magnetic Resonance Spectroscopy
4
Cisplatin
4
Specimen Handling
3
gadofosveset trisodium
2
Technetium
2
TP protocol
2
Sentinel Lymph Node Biopsy
2
Radiation Dose Hypofractionation
2
Nivolumab
2
Ipilimumab
2
Electroporation
2
Conversion to Open Surgery
2
Control Groups
2
Chemotherapy, Adjuvant
2
Chemoradiotherapy
2
Artificial Intelligence
2
tislelizumab
1
sarcolipin
1
radium Ra 223 dichloride
1
peposertib
1
pembrolizumab
1
lncRNA LNMAT1, human
1
gewf solution
1
fluoroazomycin arabinoside
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Lymphatic Metastasis
×
Radiation Dose Hypofractionation
×
Clear all
NCT03796767
2026-01-28
SOAR
University of Utah
Phase 2
Active not recruiting
20 enrolled
26 charts
NCT03280719
2024-09-19
PRO-SURF
University Hospital, Ghent
Phase NA
Completed
61 enrolled